Current status of SOD1 mutations in familial amyotrophic lateral sclerosis

Amyotrophic Lateral Sclerosis

Volumn 1, Issue 2, 2000, Pages 83-89

  Mara, Gaudette ^a   Hirano, Makito ^a   Siddique, Teepu ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

amyotrophic lateral sclerosis; superoxide dismutase

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; SUPEROXIDE DISMUTASE;

AMINO ACID SUBSTITUTION; AMYOTROPHIC LATERAL SCLEROSIS; GENETICS; HUMAN; POINT MUTATION; REVIEW;

AMINO ACID SUBSTITUTION; AMYOTROPHIC LATERAL SCLEROSIS; HUMANS; POINT MUTATION; SUPEROXIDE DISMUTASE;

EID: 79961149073     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.1080/14660820050515377     Document Type: Review

References (78)

1. McGuire V, Longstreth WT, Koepsell TD, van Belle G. Incidence of amyotrophic lateral sclerosis in three counties in western Washington state. Neurology 1996; 47: 571-573. (Pubitemid 26324064)
2. Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman O. Incidence and prevalence of ALS in Ireland, 1995-1997: A population-based study. Neurology 1999; 52: 504-509. (Pubitemid 29075594)
3. Tandan R, Bradley WG. Amyotrophic lateral sclerosis. Part 1. Clinical features, pathology, and ethical issues in management. Ann Neurol 1985; 18: 271-280. (Pubitemid 15023099)
4. Emery AEH, Holloway S. Familial motor neuron disease. In: Rowland LP, ed. Human Motor Neuron Diseases. Raven Press, New York 1982: 139-147.
5. Siddique T, Pericak-Vance MA, Brooks BR, et al. Linkage analysis in familial amyotrophic lateral sclerosis. Neurology 1989; 39: 919-925. (Pubitemid 19170414)
6. Juneja T, Pericak-Vance MA, Laing NG, Dave S, Siddique T. Prognosis in familial amyotrophic lateral sclerosis: Progression and survival in patients with glu100gly and ala4val mutations in Cu,Zn superoxide dismutase. Neurology 1997; 48: 55-57. (Pubitemid 27039517)
7. Mulder DW, Kurland LT, Offord KP, Beard CM. Familial adult motor neuron disease: Amyotrophic lateral sclerosis. Neurology 1986; 36: 511-517. (Pubitemid 16070005)
8. Siddique T. Molecular genetics of familial amyotrophic lateral sclerosis. Adv Neurol 1991; 56: 227-231.
9. Williams DB, Floate DA, Leicester J. Familial motor neuron disease: differing penetrance in large pedigrees. J Neurol Sci 1988; 86: 215-230.
10. Applebaum JS, Roos RP, Salazar-Grueso EF, et al. Intrafamilial heterogeneity in hereditary motor neuron disease. Neurology 1992; 42: 1488-1492.
11. Siddique T, Figlewicz DA, Pericak-Vance MA, et al. Linkage of a gene causing familial amyotrophic lateral sclerosis to chromosome 21 and evidence of genetic-locus heterogeneity. N Eng J Med 1991; 324: 1381-1384.
12. Rosen DR, Siddique T, Patterson D, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993; 362: 59-63; 1047-1051.
13. Deng H-X, Hentati A, Tainer JA, et al. Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismu-tase. Science 1993; 261: 1047-1051. (Pubitemid 23300865)
14. Sjalander A, Beckman G, Deng HX, Iqbal Z, Siddique T. The D90A mutation results in a polymorphism of Cu,Zn superoxide dismutase that is prevalent in northern Sweden and Finland. Hum Mol Genet 1995; 4: 1105-1108.
15. Esteban J, Rosen DR, Bowling AC, et al. Identification of two novel mutations and a new polymorphism in the gene for Cu/Zn superoxide dismutase in patients with amyotrophic lateral sclerosis. Hum Mol Genet 1994; 3: 997-998. (Pubitemid 24189974)
16. Reaume AG, Elliott JF, Hoffman EK, et al. Motor neurons in Cu/Zn superoxide dismutase deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nature Genet 1996; 13: 43-47. (Pubitemid 26139292)
17. Gurney ME, Pu H, Chiu AY, et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismu-tase mutation. Science 1994; 264: 1772-1775. (Pubitemid 24227760)
18. Wiedau-Pazos M, Gotto JJ, Rabizadeh S, et al. Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science 1996; 271: 515-518. (Pubitemid 26044472)
19. Zu JS, Deng H-X, Lo TP, et al. Exon 5 encoded domain is not required for the toxic function of mutant SOD1 but essential for the dismutase activity: Identiication and characterization of two new SOD1 mutations associated with familial amyo-trophic lateral sclerosis. Neurogenet 1998; 1: 65-71. (Pubitemid 127709611)
20. Shaw CE, Enayat ZE, Chioza BA, et al. Mutations in all five exons of SOD-1 may cause ALS. Ann Neurol 1998; 43: 390-394. (Pubitemid 28113604)
21. Andersen PM, Nilsson P, Keranen ML, et al. Phenotypic heterogeneity in motor neuron disease patients with CuZn-superoxide dismutase mutations in Scandinavia. Brain 1997; 120: 1723-1737. (Pubitemid 27443049)
22. Boukaftane Y, Khoris J, Moulard B, et al. Identification of six novel SOD1 gene mutations in familial amyotrophic lateral sclerosis. Can J Neurol Sci 1998; 25: 192-196. (Pubitemid 28368793)
23. Siddique T, Nijhawan D, Hentati A. Molecular genetic basis of familial ALS. Neurology 1996; 47(Suppl 2): S27-S35. (Pubitemid 26361992)
24. Siddique T, Deng H-X. Genetics of amyotrophic lateral sclerosis. Hum Mol Genet 1996; 5: 1465-1470. (Pubitemid 26293909)
25. Cudkowicz ME, McKenna-Yasek D, Sapp PE, et al. Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis. Ann Neurol 1997; 41: 210-221. (Pubitemid 27082102)
26. Sobue G, Doyu M, Nakano N, et al. Homozygosity for Machado-Joseph disease gene enhances phenotypic severity. J Neurol Neurosurg Psychiatry 1996; 60: 354-356. (Pubitemid 26081162)
27. Ikeuchi T, Takano H, Koide R, et al. Spinocerebellar ataxia type 6: CAG repeat expansion in alpha1A voltage-dependent calcium channel gene and clinical variations in Japanese population. Ann Neurol 1997; 42: 879-884. (Pubitemid 28008418)
28. Hayward C, Brock D, Minns R, Swingler R. Homozygosity for Asn86Ser mutation in CuZn-superoxide dismutase gene produces a severe clinical phenotype in a juvenile onset case of familial amyotrophic lateral sclerosis (letter). J Med Genet 1998; 35: 174. (Pubitemid 28156526)
29. Al-Chalabi A, Anderson PM, Chioza B, et al. Recessive amyotrophic lateral sclerosis families with the D90A SOD1 mutation share a common founder: evidence for a linked protective factor. Hum Mol Genet 1998; 7: 2045-2050. (Pubitemid 28546412)
30. Dal Canto MC, Gurney ME. A low expressor line of transgenic mice carrying a mutant human Cu,Zn superoxide dismutase (SOD1) gene develops pathological changes that most closely resemble those in human amyotrophic lateral sclerosis. Acta Neuropathol 1997; 93: 537-550. (Pubitemid 27239242)
31. Aoki M, Ogasawara M, Matsubara Y, et al. Mild ALS in Japan associated with novel SOD mutation. Nature Genet 1993; 5: 323-324. (Pubitemid 23351300)
32. Orrell RW, Habgood JJ, Gardiner I, et al. Clinical and functional investigation of 10 missence mutations and a novel frameshift insertion mutation of the gene for copper-zinc superoxide dismutase in UK families with amyotrophic lateral sclerosis. Neurology 1997; 48: 746-751. (Pubitemid 27120118)
33. Suthers G, Laing N, Wilton S, Dorosz S, Waddy H. 'Sporadic' motor neuron disease due to familial SOD1 mutation with low penetrance (letter). Lancet 1994; 344: 1773.
34. Anderson PM, Nilsson P, Keranen ML, et al. Phenotypic heterogeneity in motor neuron disease patients with CuZn-superoxide dismutase mutations in Scandinavia. Brain 1997; 120: 1723-1737. (Pubitemid 27443049)
35. Jackson M, Al-Chalabi A, Enayat ZE, Chioza B, Leigh P, Morrison K. Copper/zinc superoxide dismutase 1 and sporadic amyotrophic lateral sclerosis: Analysis of 155 cases and identification of a novel insertion mutation. Ann Neurol 1997; 42; 803-807. (Pubitemid 27481554)
36. Kawamata J, Shimohama S, Takano S, Harada K, Ueda K, Kimura J. Novel G16S (GGC-AGC) mutation in the SOD-1 gene in a patient with apparently sporadic young onset amyotrophic lateral sclerosis. Hum Mutat 1997; 9: 356-358. (Pubitemid 27157655)
37. Jones CT, Swinger RJ, Brock DJH. Identiication of a novel exon 4 SOD1 mutation in an apparently sporadic amyotrophic lateral sclerosis patient and the detection of Ile113Thr in three others. Hum Mol Genet 1994; 3: 649-650.
38. Jones CT, Shaw PJ, Chari G, Brock DJ. Identiication of a novel exon 4 SOD1 mutation in a sporadic amyotrophic lateral sclerosis patient. Mol Cell Probes 1994; 8: 329-330. (Pubitemid 24324606)
39. Hosler BA, Nicholson GA, Sapp PC, et al. Three novel mutations and two variants in the gene for Cu/Zn superoxide dismutase in familial amyotrophic lateral sclerosis. Neuromusc Disord 1996; 6: 361-366. (Pubitemid 26388003)
40. Gurney ME, Cutting FB, Ping Z, et al. Benefit of Vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis. Ann Neurol 1996; 39: 147-157. (Pubitemid 26071564)
41. Barneoud P, Curet O. Beneicial effects of lysine acetylsalicy-late, a soluble salt of aspirin, on motor performance in a transgenic model of amyotrophic lateral sclerosis. Exp Neurol 1999; 155: 243-251. (Pubitemid 29124717)
42. Hottinger AF, Fine EG, Gurney ME, Zurn AE, Aebischer P. The copper chelator d-penicillamine delays onset of disease and extends survival in a transgenic mouse model of familial amyotrophic lateral sclerosis. Eur J Neurosci 1997; 9: 1548-1551. (Pubitemid 27303257)
43. Trieu VN, Uckun FM. Genistein is neuroprotective in murine models of familial amyotrophic lateral sclerosis and stroke. Biochem Biophys Res Comm 1999; 258: 658-688.
44. Klivenyi P, Ferrante RJ, Matthews RT, et al. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nature Med 1999; 5: 347-350. (Pubitemid 29124375)
45. Matthews RT, Yang L, Browne S, Baik M, Beal MF. Coenzyme Q10 administration increases mitochondrial concentrations and exerts neuroprotective effects. Proc Natl Acad Sci USA 1998; 95: 8892-8897.
46. Nagano S, Ogawa Y, Yanagihara T, Sakoda S. Benefit of combined treatment with trientine and ascorbate in familial amyotrophic lateral sclerosis model mice. Neurosci Lett 1999; 265: 159-162. (Pubitemid 29207390)
47. Mazzini L, Mora G, Balzarini C, et al. The natural history and the effects of gabapentin in amyotrophic lateral sclerosis. J Neurol Sci 1998; 160(Suppl 1): S57-S63. (Pubitemid 28522520)
48. Riviere M, Meininger V, Zeisser P, Munsat T. An analysis of extended survival in patients with amyotrophic lateral sclerosis treated with riluzole. Arch Neurol 1998; 55: 526-528. (Pubitemid 28182699)
49. Vyth A, Timmer JG, Bossuyt PM, Louwerse ES, de Jong JM. Survival in patients with amyotrophic lateral sclerosis, treated with an array of antioxidants. J Neurol Sci 1996; 139(Suppl): 99-103.
50. Gurney ME. The use of transgenic mouse models of amyo-trophic lateral sclerosis in preclinical drug stories. J Neurol Sci. 1997; 152(Suppl 1); S67-S73. (Pubitemid 27505293)
51. Simpson SA, Harding AE. Predictive testing for Huntington's disease: after the gene. The United Kingdom Huntington's Disease Prediction Consortium. J Med Genet 1993; 30: 1036-1038.
52. De Wert G. Ethics of predictive DNA-testing for hereditary breast and ovarian cancer. Patient Educ Couns 1998; 35: 43-52. (Pubitemid 29037813)
53. Nakanishi T, Masahiko K, Miyazaki A, et al. Simple and deined method to detect the SOD-1 mutants from patients with familial amyotrophic lateral sclerosis by mass spectrometry. J Neurosci Methods 1998; 81: 41-44. (Pubitemid 28293717)
54. Nakano R, Sato S, Inuzuka T, et al. A novel mutation in Cu/Zn superoxide dismutase gene in Japanese familial amyotrophic lateral sclerosis. Biochem Biophys Res Commun 1994; 200: 695-703. (Pubitemid 24146018)
55. Morita M, Aoki M, Abe K, et al. A novel two-base mutation in the Cu/Zn superoxide dismutase gene associated with familial amyotrophic lateral sclerosis in Japan. Neurosci Lett 1996; 205; 79-82. (Pubitemid 26071319)
56. Hirano M, Fujii J, Nagai Y, et al. A new variant Cu/Zn superoxide dismutase (Val7Glu) deduced from lymphocyte mRNA sequences from Japanese patients with familial amyotrophic lateral sclerosis. Biochem Biophys Res Commun 1994; 204: 572-577. (Pubitemid 24343958)
57. Bereznai B, Winkler A, Borasio GD, Gasser T. A novel SOD1 mutation in an Austrian family with amyotrophic lateral sclerosis. Neuromuscular Disord 1997; 7: 113-116. (Pubitemid 27168712)
58. Penco S, Schenone A, Bordo D, et al. A SOD1 gene mutation in a patient with slowly progressing familial ALS. Neurology 1999; 53: 404-406. (Pubitemid 29344368)
59. Deng H-X, Tainer JA, Mitsumoto H, et al. Two novel SOD1 mutations in patients with familial amyotrophic lateral sclerosis. Hum Mol Genet 1995; 4: 1113-1116.
60. Hung W-Y, Yang Y, Caliendo J, et al. Two novel SOD1 mutations in familial amyotrophic lateral sclerosis (abstract). The American Society of Human Genetics Meeting, 1998; Denver, The University of Chicago Press, Chicago.
61. Moulard B, Camu W, Brice A, et al. A previously undescribed mutation in the SOD1 gene in a French family with atypical ALS (abstract). Sixth International Symposium on ALS/MND, 1995; Dublin. The University of Chicago Press, Chicago.
62. Enayat ZE, Orrell RW, Claus A, et al. Two novel mutations in the gene for copper zinc superoxide dismutase in UK families with amyotrophic lateral sclerosis. Hum Mol Genet 1995; 4: 1239-1240.
63. Hung W-Y, Yang Y, Kaplan JP, et al. A novel SOD1 mutation in familial amyotrophic lateral sclerosis (abstract). The American Society of Human Genetics Meeting, 1997; Baltimore, MD. The University of Chicago Press, Chicago.
64. Morita M, Abe K, Takahashi M, et al. A novel mutation Asp90Val in the SOD1 gene associated with Japanese familial ALS. Eur J Neurol 1998; 5: 389-392. (Pubitemid 28365283)
65. Elshafey A, Lanyon WG, Connor JM. Identification of a new missence point mutation in exon 4 of the Cu/Zn superoxide dismutase (SOD-1) gene in a family with amyotrophic lateral sclerosis. Hum Mol Genet 1994; 3: 363-364.
66. Kawamata J, Shimohama S, Kimura J, et al. Deletion and point mutations in superoxide dismutase-1 gene in amyo-trophic lateral sclerosis (abstract). Eleventh TMIN International Symposium 1995: Tokyo.
67. Yulug IG, Katsanis N, de Belleroche J, Collinge J, Fisher EM. An improved protocol for the analysis of SOD1 gene mutations and a new mutation in exon 4. Hum Mol Genet 1995; 4: 1101-1104, 1474.
68. Ikeda M, Abe K, Aoki M, et al. Variable clinical symptoms in familial amyotrophic lateral sclerosis with a novel point mutation in the Cu/Zn superoxide dismutase gene. Neurology 1995; 45: 2038-2042.
69. De Belleroche J, Orrell RW, Habgood J, Gardiner IM, Greenwood J. A survey of Cu/Zn superoxide dismutase mutations in 70 UK families with familial amyotrophic lateral sclerosis: clinical correlation (abstract). HUGO's Human Genome Meeting. 1996; Heidelberg.
70. De Belleroche J, Orrell R, Markluind S, et al. Functional and structural correlates of 12 superoxide dismutase-1 mutations in UK families with amyotrophic lateral sclerosis (abstract). Sixth International Symposium on ALS/MND, 1995; Dublin. The University of Chicago Press, Chicago.
71. Kostrzewa M, Burck-Lehmann U, Müller U. Autosomal dominant amyotrophic lateral sclerosis: a novel mutation in the Cu/Zn superoxide dismutase-1 gene. Hum Mol Genet 1994; 3: 2261-2262.
72. Watanabe M, Aoki M, Abe K, et al. A novel missence point mutation (S134N) of the Cu/Zn superoxide dismutase gene in a patient with familial motor neuron disease. Hum Mutation 1997; 9: 69-71. (Pubitemid 27024037)
73. Pramatarova A, Figlewicz DA, Krizus A, et al. Identiication of new mutations in the Cu/Zn superoxide dismutase gene of patients with familial amyotrophic lateral sclerosis. Am J Hum Genet 1995; 56: 592-596.
74. Ikeda M, Abe K, Aoki M, et al. A novel point mutation in the Cu/Zn superoxide dismutase gene in a patient with familial amyotrophic lateral sclerosis. Hum Mol Genet 1995; 4: 491-492.
75. Kostrzewa M, Damian MS, Muller U. Superoxide dismutase 1: Identiication of a novel mutation in a case of familial amyotrophic lateral sclerosis. Hum Genet 1996; 98: 48-50. (Pubitemid 26181280)
76. Pramatarova A, Goto J, Nanba E, et al. A two basepair deletion in the SOD1 gene causes familial amyotrophic lateral sclerosis. Hum Mol Genet 1994; 3: 2061-2062. (Pubitemid 24341387)
77. Sapp PC, Rosen DR, Hosler BA, et al. Identiication of three novel mutations in the gene for Cu/Zn superoxide dismutase in patients with familial amyotrophic lateral sclerosis. Neuromuscular Disord 1995; 5: 353-357.
78. Shaw PJ, Tomkins J, Slade JY, et al. CNS tissue Cu/Zn superoxide dismutase (SOD1) mutations in motor neurone disease (MND). Neuroreport 1997; 8: 3923-3927. (Pubitemid 28027210)